QNRX QUOIN PHARMACEUTICALS LTD Management Changes 8-K Filing 2024 - Merger and Sale Quoin Pharmaceuticals, Ltd. completed a merger with Cellect Biotechnology Ltd. and changed its name, while also completing the sale of its subsidiary to EnCellX, Inc. The contingent value rights (CVRs) distributed in connection with the sale have been terminated.Get access to all SEC 8-K filings of the QUOIN PHARMACEUTICALS LTD